About Elizabeth Leiderman
Form D filings for Atsena Therapeutics in 2023 list Elizabeth Leiderman as executive officer.
Elizabeth Leiderman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Elizabeth Leiderman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Elizabeth Leiderman works with at each company, as listed on that company's latest Form D.
Atsena Therapeutics, Inc. · Form D, Oct 2, 2023
MD
Michael Dial
Director
JW
Jennifer Wellman
Director
JG
Jacqueline Grant
Director
PR
Patrick Ritschel
Chief Executive Officer and director
SB
Shannon Boye
Director
JH
James Healy
Director
CI
Christina Isacson
Director